Editorial · 2012
Research articlePublished 2012
Inhibitory Effects of the Dual Endothelin Receptor Blocker Bosentan on Thrombin-Activated Lung Fibroblasts Isolated from Scleroderma Patients
Subjects
RheumatologyOrthopaedicsSimilar by topic
Review article · 2012
Scleroderma Lung Disease – Other Lung Complications in Systemic Sclerosis
Research article · 2012
Limited Cutaneous and Diffuse Cutaneous Scleroderma: Circulating Biomarkers Differentiate Lung Involvement
Review article · 2012
Interstitial Lung Disease in Scleroderma: Clinical Features and Pathogenesis
Review article · 2012
Scleroderma Lung Fibrosis and Biologic Drugs
More from this journal
The newest in Rheumatology: Current Research.
Opinion · 19 Dec 2025
The Future of Rheumatology: Growth and Innovation
Opinion · 19 Dec 2025
Specialized Care for Complex Rheumatic Disorders
Perspective · 19 Dec 2025
Rheumatology and Musculoskeletal Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalRheumatology: Current Research
- SubjectRheumatology
- SubjectOrthopaedics
- BylineArticles whose byline prints “Galina S Bogatkevich”
- BylineArticles whose byline prints “Tanjina Akter”
- BylineArticles whose byline prints “Anna Ludwicka-Bradley”
- BylineArticles whose byline prints “Richard M Silver”

